These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16828769)

  • 1. Prolonged ovarian hyperstimulation for poor responders in in-vitro fertilization treatment cycles.
    Ahmad G; Lewis-Jones DI; Gazvani R
    Int J Gynaecol Obstet; 2006 Aug; 94(2):141-2. PubMed ID: 16828769
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilization.
    Wei Z; Cheng X; Li H; Cao Y; Cong L; Zhou P; Li J
    Reprod Biol Endocrinol; 2010 Mar; 8():26. PubMed ID: 20236519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified natural-cycle in vitro fertilization should be considered as the first approach in young poor responders.
    Kadoch IJ; Phillips SJ; Bissonnette F
    Fertil Steril; 2011 Nov; 96(5):1066-8. PubMed ID: 22036050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization.
    Kwee J; Elting ME; Schats R; McDonnell J; Lambalk CB
    Reprod Biol Endocrinol; 2007 Mar; 5():9. PubMed ID: 17362511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
    Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancellation of IVF-ET cycles: poor prognosis, poor responder, or variability of the response to controlled ovarian hyperstimulation? An analysis of 142 cancellations].
    Lamazou F; Fuchs F; Grynberg M; Gallot V; Herzog E; Fanchin R; Frydman N; Frydman R
    J Gynecol Obstet Biol Reprod (Paris); 2012 Feb; 41(1):41-7. PubMed ID: 21835556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists.
    Rabinson J; Ashkenazi J; Homburg R; Meltcer S; Anteby EY; Orvieto R
    Fertil Steril; 2009 Apr; 91(4 Suppl):1473-5. PubMed ID: 18937940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited.
    Zarek SM; Muasher SJ
    Fertil Steril; 2011 Jun; 95(8):2449-55. PubMed ID: 21550037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen supplementation in IVF.
    Kim CH
    Minerva Ginecol; 2013 Oct; 65(5):497-504. PubMed ID: 24096287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
    Kedem A; Tsur A; Haas J; Yerushalmi GM; Hourvitz A; Machtinger R; Orvieto R
    Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encountering premature ovulation during controlled ovarian hyperstimulation in IVF/ICSI cycles.
    Wu FS; Lee RK; Hwu YM
    Taiwan J Obstet Gynecol; 2012 Jun; 51(2):256-9. PubMed ID: 22795104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
    Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
    Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What are the best predictors for successful GnRH antagonist protocol in in vitro fertilization (IVF) treatment?
    Samara N; Reis D; Danielli Miller N; Ghetler Y; Berkovitz A; Miller M; Gonen O; Shulman A; Wiser A
    Gynecol Endocrinol; 2015; 31(11):877-9. PubMed ID: 26416777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates.
    Atkinson P; Koch J; Ledger WL
    Aust N Z J Obstet Gynaecol; 2014 Dec; 54(6):581-5. PubMed ID: 25476811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of salpingectomy on ovarian response in controlled ovarian hyperstimulation for in vitro fertilization: a reappraisal.
    Almog B; Wagman I; Bibi G; Raz Y; Azem F; Groutz A; Barkan G; Holzer H; Amit A; Tulandi T; Levin I
    Fertil Steril; 2011 Jun; 95(8):2474-6. PubMed ID: 21474129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation.
    Kolibianakis E; Zikopoulos K; Camus M; Tournaye H; Van Steirteghem A; Devroey P
    Hum Reprod; 2004 Nov; 19(11):2545-9. PubMed ID: 15471941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria.
    Polyzos NP; Blockeel C; Verpoest W; De Vos M; Stoop D; Vloeberghs V; Camus M; Devroey P; Tournaye H
    Hum Reprod; 2012 Dec; 27(12):3481-6. PubMed ID: 22940767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.
    Orvieto R; Zohav E; Scharf S; Rabinson J; Meltcer S; Anteby EY; Homburg R
    Gynecol Endocrinol; 2007 Feb; 23(2):72-5. PubMed ID: 17454155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.